1. Effects of antiepileptic drugs on reproductive endocrine function, sexual function and sperm parameters in Chinese Han men with epilepsy
- Author
-
Xu Yao, Zhao Zhipan, Xu Xiaotian, Wu Yumei, Xu Daoliang, and Zhang Hengzhong
- Subjects
Adult ,Male ,medicine.medical_specialty ,Levetiracetam ,Adolescent ,Young Adult ,Sex hormone-binding globulin ,Asian People ,Erectile Dysfunction ,Physiology (medical) ,Internal medicine ,medicine ,Humans ,Endocrine system ,Testosterone ,Infertility, Male ,Sperm motility ,Epilepsy ,biology ,business.industry ,Valproic Acid ,General Medicine ,Luteinizing Hormone ,Middle Aged ,Piracetam ,Spermatozoa ,Sperm ,Endocrinology ,Neurology ,biology.protein ,Anticonvulsants ,lipids (amino acids, peptides, and proteins) ,Surgery ,Neurology (clinical) ,Follicle Stimulating Hormone ,Sexual function ,Luteinizing hormone ,business ,Hormone - Abstract
The effects of the antiepileptic drugs sodium valproate (VPA) and levetiracetam (LEV) on reproductive endocrine function, sexual function, and spermatozoa were explored, together with their possible etiological mechanisms, in Chinese Han men with epilepsy. Following VPA treatment (n = 32), luteinizing hormone and follicle-stimulating hormone levels were significantly lower than in controls (n = 30). The bioactive testosterone/luteinizing hormone ratio and the prolactin level were significantly elevated in the VPA treatment group. There were no significant differences in these hormones between the LEV treatment (n = 20) and control groups. The rates of sperm morphologic abnormality (head, body, and tail) were significantly higher in the VPA treatment group than the control group but did not differ significantly between the LEV treatment and control groups. The sperm motility rate was significantly lower in the VPA treatment group (grade A sperm motility rate
- Published
- 2013